Literature DB >> 11788214

Prognostic significance of peripheral monocytosis after reperfused acute myocardial infarction:a possible role for left ventricular remodeling.

Yuichiro Maekawa1, Toshihisa Anzai, Tsutomu Yoshikawa, Yasushi Asakura, Toshiyuki Takahashi, Shiro Ishikawa, Hideo Mitamura, Satoshi Ogawa.   

Abstract

OBJECTIVES: The aim of this study was to determine the significance of peripheral monocytosis in clinical outcome after reperfused acute myocardial infarction (AMI), especially relating to post-infarct left ventricular (LV) remodeling.
BACKGROUND: Peripheral monocytosis occurs two to three days after AMI, reflecting infiltration of monocytes and macrophages into the necrotic myocardium. However, the prognostic significance of peripheral monocytosis after AMI remains to be determined.
METHODS: A total of 149 patients with first Q-wave AMI were studied. White blood cell (WBC) count, percentage of monocytes and serum C-reactive protein level were measured every 24 h for four days after the onset of AMI. We assessed association between peripheral monocytosis and prognosis including pump failure, LV aneurysm and long-term outcome after AMI.
RESULTS: Patients with pump failure (p < 0.0001) or LV aneurysm (p = 0.005) had higher peak monocyte counts than those without these complications. Predischarge left ventriculography revealed that peak monocyte count was positively correlated with LV end-diastolic volume (p = 0.024) and negatively correlated with ejection fraction (p = 0.023). Multivariate analyses showed that peak monocyte count > or = 900/mm(3) was an independent determinant of pump failure (relative risk [RR] 9.83, p < 0.0001), LV aneurysm (RR 4.78, p = 0.046) and cardiac events (RR 6.30, p < 0.0001), including readmission for heart failure, recurrent myocardial infarction and cardiac deaths, including sudden deaths.
CONCLUSIONS: Peripheral monocytosis is associated with LV dysfunction and LV aneurysm, suggesting a possible role of monocytes in the development of LV remodeling after reperfused AMI.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11788214     DOI: 10.1016/s0735-1097(01)01721-1

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  94 in total

Review 1.  Monocytes: protagonists of infarct inflammation and repair after myocardial infarction.

Authors:  Matthias Nahrendorf; Mikael J Pittet; Filip K Swirski
Journal:  Circulation       Date:  2010-06-08       Impact factor: 29.690

Review 2.  Phenotyping patient-derived cells for translational studies in cardiovascular disease.

Authors:  Stanley Y Shaw; Ari D Brettman
Journal:  Circulation       Date:  2011-11-29       Impact factor: 29.690

3.  Relationship between residual viable myocardium and LV remodeling post-MI: Only part of the story.

Authors:  Robert J Gropler
Journal:  J Nucl Cardiol       Date:  2016-02-17       Impact factor: 5.952

4.  Admission Low-Density Lipoprotein Cholesterol Stratified by Circulating CD14++CD16+ Monocytes and Risk for Recurrent Cardiovascular Events Following ST Elevation Myocardial Infarction: Lipid Paradox Revised.

Authors:  Shaozhuang Dong; Wenjie Ji; Shan Zeng; Jun Miao; Lifang Yan; Xinlin Liu; Junxiang Liu; Xin Zhou; Qing Yang
Journal:  J Cardiovasc Transl Res       Date:  2020-06-18       Impact factor: 4.132

5.  Enhanced efferocytosis of apoptotic cardiomyocytes through myeloid-epithelial-reproductive tyrosine kinase links acute inflammation resolution to cardiac repair after infarction.

Authors:  Elaine Wan; Xin Yi Yeap; Shirley Dehn; Rachael Terry; Margaret Novak; Shuang Zhang; Shinichi Iwata; Xiaoqiang Han; Shunichi Homma; Konstantinos Drosatos; Jon Lomasney; David M Engman; Stephen D Miller; Douglas E Vaughan; John P Morrow; Raj Kishore; Edward B Thorp
Journal:  Circ Res       Date:  2013-07-08       Impact factor: 17.367

Review 6.  Cellular immunity and cardiac remodeling after myocardial infarction: role of neutrophils, monocytes, and macrophages.

Authors:  Hisahito Shinagawa; Stefan Frantz
Journal:  Curr Heart Fail Rep       Date:  2015-06

Review 7.  Could interferon-gamma be a therapeutic target for treating heart failure?

Authors:  Scott P Levick; Paul H Goldspink
Journal:  Heart Fail Rev       Date:  2014-03       Impact factor: 4.214

8.  Relation of circulating interleukin-6 to left ventricular remodeling in patients with reperfused anterior myocardial infarction.

Authors:  Tomoaki Ohtsuka; Mareomi Hamada; Katsuji Inoue; Kiyotaka Ohshima; Jun Sujzuki; Tsuyoshi Matsunaka; Akiyoshi Ogimoto; Yuji Hara; Yuji Shigematsu; Jitsuo Higaki
Journal:  Clin Cardiol       Date:  2004-07       Impact factor: 2.882

9.  18F-4V for PET-CT imaging of VCAM-1 expression in atherosclerosis.

Authors:  Matthias Nahrendorf; Edmund Keliher; Peter Panizzi; Hanwen Zhang; Sheena Hembrador; Jose-Luiz Figueiredo; Elena Aikawa; Kimberly Kelly; Peter Libby; Ralph Weissleder
Journal:  JACC Cardiovasc Imaging       Date:  2009-10

10.  Emerging hematological targets and therapy for cardiovascular disease: From bench to bedside.

Authors:  Ana Villegas; Fernando A Gonzalez; Leopoldo Llorente; Santiago Redondo
Journal:  Biologics       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.